Your fact-checks will appear here
The use of Ivermectin for controlling malaria vectors, including its potential interactions and effects on different populations.
There is no single, authoritative global tally of confirmed deaths attributable to ivermectin toxicity; available reporting offers scattered case series and individual reports rather than a comprehens...
Only a single actively registered randomized or early-phase trial of ivermectin in human cancer patients is clearly documented in the available reporting: a phase I/II study combining oral ivermectin ...
Basal cell carcinoma () is ordinarily treated with procedures and drugs that have robust clinical evidence—surgery (including Mohs), radiotherapy, topical ‑approved agents for superficial lesions, and...
Ivermectin’s proposed anticancer effects rest on a bundle of mechanistic observations from cell and animal studies: direct disruption of tumor cell signaling and ion-homeostasis that triggers apoptosi...
Ivermectin is a proven antiparasitic drug in humans for specific infections such as onchocerciasis and scabies, but there is no convincing clinical evidence that it cures or prevents cancer in humans;...
Ivermectin’s pharmacokinetics are influenced by body composition and age in ways that often affect distribution and timing more than peak systemic exposure, while P‑glycoprotein (P‑gp) activity and CY...